Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
Recruiting · NCT06482073 · Observational (researchers observe without assigning treatment) · Lead sponsor: Mayo Clinic
View the official record on ClinicalTrials.gov →Interventions studied
Non-Interventional Study
What this trial is about
This study evaluates the effectiveness of robotic biopsies in providing information about hereditary or cancer specific genetic variants that may have a role in diagnosis of cancer and to develop genetic results and medical record databank for future studies.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subject age 18 years and older
- Subject is scheduled/was scheduled for a bronchoscopy or surgical resection as part of standard of care
- Subject with a moderate to high risk of lung cancer based on clinical demographic and radiologic information or with suspected metastatic disease
- Ability to provide blood or saliva sample
- Ability to provide archived tissue
- Subject is able to understand and adhere to study requirements and able to provide informed consent
Exclusion criteria
- Individuals who have situations that would limit compliance with the study requirements
- Institutionalized (i.e. federal medical prison)
- Pregnant
- Prior germline genetic testing with a 40+ multi-gene panel AND/OR prior somatic tissue (250+ gene) testing utilizing the tissue from the bronchoscopy or surgical resection
Where it is running
1 location listed across 1 US state.
- Mayo Clinic in Rochester - Rochester, Minnesota, United States